INSULET CORPORATION Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INSULET CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $100.00K, a 99.01% decline year-over-year.
- INSULET CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $400.00K, a 84.00% decline year-over-year.
- INSULET CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $1.80M, a 260.00% increase year-over-year.
- INSULET CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $4.60M, a 557.14% increase year-over-year.
- INSULET CORPORATION stock issued during period, value, stock options exercised for fiscal 2025 was $19.00M, a 131.71% increase from fiscal 2024.
- INSULET CORPORATION stock issued during period, value, stock options exercised for fiscal 2024 was $8.20M, a 49.69% decline from fiscal 2023.
- INSULET CORPORATION stock issued during period, value, stock options exercised for fiscal 2023 was $16.30M, a 136.23% increase from fiscal 2022.
- INSULET CORPORATION stock issued during period, value, stock options exercised for fiscal 2022 was $6.90M, a 55.19% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-08-05 | $6.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $400.00K 10-Q · filed 2026-05-06 | $16.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $19.00M 10-K · filed 2026-02-18 |
| 2025-09-30 | $4.60M 10-Q · filed 2025-11-06 | $17.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $10.10M 10-Q · filed 2026-08-05 | $13.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $2.50M 10-Q · filed 2026-05-06 | $4.80M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $8.20M 10-K · filed 2026-02-18 |
| 2024-09-30 | $700.00K 10-Q · filed 2025-11-06 | $11.50M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-30 | $1.10M 10-Q · filed 2025-08-07 | $10.90M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-31 | $5.80M 10-Q · filed 2025-05-09 | $16.10M derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $16.30M 10-K · filed 2026-02-18 |
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-08 | $15.00M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $6.30M 10-Q · filed 2024-08-09 | $17.30M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $6.00M 10-Q · filed 2024-05-10 | $11.80M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $6.90M 10-K · filed 2025-02-21 |
| 2022-09-30 | $2.40M 10-Q · filed 2023-11-03 | $9.20M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $800.00K 10-Q · filed 2023-08-09 | $11.10M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $1.10M 10-Q · filed 2023-05-05 | $15.00M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $15.40M 10-K · filed 2024-02-23 |
| 2021-09-30 | $4.30M 10-Q · filed 2022-11-04 | $14.30M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $4.70M 10-Q · filed 2022-08-05 | $20.60M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $1.50M 10-Q · filed 2022-05-06 | $21.00M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $25.70M 10-K · filed 2023-02-24 |
| 2020-09-30 | $10.60M 10-Q · filed 2021-11-05 | $27.60M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $5.10M 10-Q · filed 2021-08-06 | $34.30M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $6.20M 10-Q · filed 2021-05-07 | $43.80M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $46.60M 10-K · filed 2022-02-24 |
| 2019-09-30 | $17.30M 10-Q · filed 2020-11-05 | $41.70M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $14.60M 10-Q · filed 2020-08-07 | $26.66M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $9.00M 10-Q · filed 2020-05-08 | $18.84M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $12.80M 10-K · filed 2021-02-24 |
| 2018-09-30 | $2.26M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $6.78M 10-Q · filed 2019-08-06 | |
| 2018-03-31 | $2.96M 10-Q · filed 2019-05-03 | |
| 2017-12-31 | $14.00M 10-K · filed 2020-02-26 | |
| 2016-12-31 | $4.83M 10-K · filed 2019-02-26 | |
| 2015-12-31 | $7.20M 10-K · filed 2018-02-22 | |
| 2014-12-31 | $11.09M 10-K · filed 2017-02-28 | |
| 2013-12-31 | $9.48M 8-K · filed 2016-09-06 | |
| 2012-12-31 | $4.59M 10-K · filed 2015-02-26 | |
| 2011-12-31 | $5.24M 10-K · filed 2014-02-28 | |
| 2010-12-31 | $3.04M 10-K/A · filed 2013-02-28 | |
| 2009-12-31 | $577.00K 10-K/A · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |